Table 1 Characteristics of participants who refused and who completed by follow-up time point
6 months follow-up | 12 months follow-up | 24 months follow-up | ||||
|---|---|---|---|---|---|---|
Refused | Completed | Refused | Completed | Refused | Completed | |
Na (times asked) | 22 (18%) | 65 (54%) | 38 (31%) | 58 (48%) | 29 (40%) | 33 (46%) |
Sex | ||||||
Male | 17 (77%) | 40 (62%) | 24 (63%) | 40 (69%) | 17 (59%) | 21 (64%) |
Female | 5 (23%) | 25 (38%) | 14 (37%) | 18 (31%) | 12 (41%) | 12 (36%) |
Age, years (mean, SD) | 67.3 (12.9) | 60.7 (13.4) | 64.0 (11.4) | 61.2 (11.1) | 63.5 (11.7) | 63.0 (10.9) |
BMI kg/m2 (mean, SD) | 24.4 (4.8) | 25.6 (3.6) | 26.5 (3.9) | 26.1 (3.3) | 26.6 (4.6) | 27.5 (4.3) |
Tumor stage | ||||||
0 + I | 6 (27%) | 9 (14%) | 12 (32%) | 14 (24%) | 11 (38%) | 6 (18%) |
II | 4 (18%) | 19 (29%) | 11 (29%) | 18 (31%) | 6 (21%) | 14 (42%) |
III | 7 (32%) | 21 (31%) | 9 (24%) | 15 (26%) | 9 (31%) | 11 (33%) |
IV | 4 (18%) | 7 (11%) | 6 (16%) | 7 (12%) | 3 (10%) | 1 (3%) |
Not known | 1 (5%) | 9 (15%) | 0 | 4 (7%) | 0 | 1 (3%) |
Participation in accelerometry at prior follow-up | ||||||
6 months | n.a. | 40 | 31 (78%) | 25 | 14 (56%) | |
12 months | n.a. | n.a. | n.a. | 32 | 20 (63%) | |
6 and 12 months | n.a. | n.a. | n.a. | 19 | 13 (68%) | |